MicroPort NeuroScientific Corporation (HKG: 2172)
Hong Kong
· Delayed Price · Currency is HKD
8.18
-0.11 (-1.33%)
Jan 3, 2025, 4:08 PM HKT
MicroPort NeuroScientific Revenue
MicroPort NeuroScientific had revenue of 408.23M CNY in the half year ending June 30, 2024, with 98.17% growth. This brings the company's revenue in the last twelve months to 774.66M, up 20.94% year-over-year. In the year 2023, MicroPort NeuroScientific had annual revenue of 665.62M with 21.61% growth.
Revenue (ttm)
774.66M CNY
Revenue Growth
+20.94%
P/S Ratio
5.71
Revenue / Employee
1.36M CNY
Employees
571
Market Cap
4.72B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 665.62M | 118.27M | 21.61% |
Dec 31, 2022 | 547.35M | 164.55M | 42.99% |
Dec 31, 2021 | 382.80M | 160.88M | 72.49% |
Dec 31, 2020 | 221.92M | 38.20M | 20.79% |
Dec 31, 2019 | 183.72M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 26.04B |
Hansoh Pharmaceutical Group Company | 13.00B |
JD Health International | 58.84B |
WuXi Biologics | 18.39B |
Sinopharm Group | 634.32B |
Innovent Biologics | 8.01B |
Sino Biopharmaceutical | 29.86B |
CSPC Pharmaceutical Group | 33.53B |